2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Parallel Session 4- Innate Immunity, xenoantigens and antibodies (Xeno Track)

6.133 - Novel experimental models to test human NK cell recruitment to porcine endothelium and their role in cellular xenograft rejection

Presenter: Amandine, Pradier, Geneva, Switzerland
Authors: Amandine Pradier1, Ruhollah Heyrani Nobari1, Anne-Laure Millard2, Anjan Bongoni3, Mihai Constantinescu4, David Kiermeir4, Mårten Schneider5, Andrea Bähr6, Nikolai Klymiuk6, Robert Rieben3, Jörg D. Seebach1

133

Novel experimental models to test human NK cell recruitment to porcine endothelium and their role in cellular xenograft rejection

Amandine Pradier1, Ruhollah Heyrani Nobari1, Anne-Laure Millard2, Anjan Bongoni3, Mihai Constantinescu4, David Kiermeir4, Mårten Schneider5, Andrea Bähr6, Nikolai Klymiuk6, Robert Rieben3, Jörg D. Seebach1

1Department of Immunology and Allergology, University Hospital and Medical Faculty, Geneva, Switzerland; 2Division of Infectious Diseases, University Hospital, Zurich, Switzerland; 3Department of Clinical Research, University of Bern, Bern, Switzerland; 4Clinic of Plastic and Hand Surgery, University Hospital, Bern, Switzerland; 5Laboratory of Vascular Immunology, University Hospital, Zurich, Switzerland; 6Institute of Molecular Animal Breeding and Biotechnology, Ludwig-Maximilian University, Munich, Germany

In vitro, interactions between human NK cells and porcine endothelial cells (pEC) are characterized by NK cell recruitment and cytotoxicity. Protection from xenogeneic NK cytotoxicity under static conditions was achieved by the expression of HLA-E on pEC and blocking of activating NK receptors. However, this strategy has not yet been tested under physiological shear stress or in vivo/ex vivo. Therefore, the aims of this study were to evaluate whether human NK cells damage pEC in a flow system and to study NK cell recruitment and infiltration of porcine tissues using an ex vivo perfusion system of HLA-E transgenic pig legs with human blood.

Monolayers of pEC were perfused in vitro with human NK cells in a flow chamber for several hours. NK cells adhesion and transmigration was observed from the beginning, however, damage of the layer was noted only after 6h of perfusion. Two wild type and 2 HLA-E/CD46 transgenic pig legs were perfused ex vivo with heparinized human blood. Blood samples were collected at several time points and PBMC were analyzed by FACS. A strong diminution of NK cells was observed after 7h of perfusion in both the wild type and the transgenic legs. However, this decrease occurred earlier in the wild type leg than in the transgenic. In addition, the apparition of a SLA-I+ cells population of pig origin was observed.

These results confirmed previous in vitro studies demonstrating that pEC damage was mediated by human NK cells. Moreover, our preliminary results showed that the expression of HLA-E/CD46 provided a partial protection with regard to NK cell recruitment and tissue infiltration. In conclusion, these systems represent powerful tools to study the basic molecular mechanisms taking place in a setting of xenotransplantation and to evaluate the protection from early cell-mediated rejection mechanisms in tissues originating from transgenic pigs.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada